Nanotech Needs a Hard Sell, Plus Education

Startling advances are being made in the emerging field of nanotechnology. For example, Naomi Halas and Jennifer West of Rice University in Houston recently announced that their nanoshells had proven effective at eradicating tumors in lab animals1; researchers at Harvard University reported creating hybrid nanowires that could be linked to conventional silicon circuits2; and government scientists at Argonne National Laboratory in Chicago documented how they had engineered nanoparticles capable o

Written byJack Uldrich
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Startling advances are being made in the emerging field of nanotechnology. For example, Naomi Halas and Jennifer West of Rice University in Houston recently announced that their nanoshells had proven effective at eradicating tumors in lab animals1; researchers at Harvard University reported creating hybrid nanowires that could be linked to conventional silicon circuits2; and government scientists at Argonne National Laboratory in Chicago documented how they had engineered nanoparticles capable of cleaning buildings exposed to radioactive materials.3

• Participatory and/or constructive technology assessment with stakeholders, particularly that which takes account of the dynamic interrelations between society and the development of nanotechnologies (see, for example, Rip et al., 1995).

• Scenario analysis with stakeholders to identify significant uncertainties that might emerge with nanotechnologies For example, the GM 'shocks and surprises' seminar organized by the Cabinet Office (2003).

• Direct public engagement such as citizen juries or panels for identifying at an early ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies